Archive for January 4th, 2009

M2 Presswire - Depomed Begins Dosing Patients in Phase 2 Trial For Gabapentin GR to Treat Menopausal Hot Flashes.

Sunday, January 4th, 2009

M2 PRESSWIRE-14 June 2007-ExplorationInvestor: Depomed Begins Dosing Patients in Phase 2 Trial For Gabapentin GR to Treat Menopausal Hot Flashes(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:14062007 Exploration Investor strives to provide…